Cystic fibrosis in Greece: molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high‐risk individuals
- 7 May 2003
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 63 (5) , 400-409
Abstract
Cystic fibrosis (CF) mutation analysis on 437 CF patients, characterized 80 different mutations (20 so far specific to our population) accounting for 91% of CF genes and generating 103 different genotypes. Eight mutations were common [F508del (53.4%), 621+1G>T (5.7%), G542X (3.9%), N1303K (2.6%), 2789+5G>A (1.7%), 2183AA>G (1.4%), E822X (1.4%), R1158X (1%)], 12 showed frequencies between 0.5% and 1%, while the remaining (60) were very rare (1 to 3 alleles). Denaturing gradient gel electrophoresis (DGGE) screening of 12 exons (3, 4, 7, 10, 11, 13, 14b, 16, 17b 20 and 21) detected 85.5% of CF alleles. Haplotypes for eight diallelic and three microsatellite markers have been characterized for the common, a few rare and novel Greek mutations. Results of 165 prenatal diagnoses (including 49 due to bowel hyperechogenicity), testing a total of 41 different parental genotypes, are reported. One hundred and sixteen prenatal tests resulted in 22 affected, 59 heterozygous, 34 normal fetuses and one incomplete diagnosis. Of the 49 echogenic bowel fetuses, 3 were heterozygotes. Carrier screening was initiated, with emphasis on individuals and couples in high‐risk groups – with a family history of CF, one partner with CF, and couples with male infertility seeking in vitro fertilization (IVF). Mutation analysis on 672 individuals (120 couples, 91 unaffected CF siblings, 283 CF family relatives and 58 general population subjects), identified a total of 176 heterozygotes and 7 couples where both partners were CF heterozygotes. Prenatal diagnosis was performed in 4 cases and 3 were counseled on the availability of a prenatal test.Keywords
This publication has 39 references indexed in Scilit:
- Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717–9T→C-D565G) and one nonsense mutation (E822X) in the CFTR geneHuman Genetics, 2001
- Fetal echogenic bowel: parameters to be considered in differential diagnosisUltrasound in Obstetrics & Gynecology, 2000
- The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American populationPrenatal Diagnosis, 1999
- Cystic fibrosis mutations and associated haplotypes in Bulgaria - a comparative population genetic studyHuman Genetics, 1997
- CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern FranceHuman Genetics, 1996
- PRENATAL DIAGNOSIS OF CYSTIC FIBROSIS IN A HIGHLY HETEROGENEOUS POPULATIONPrenatal Diagnosis, 1996
- Mutation analysis in 600 French cystic fibrosis patients.Journal of Medical Genetics, 1994
- Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracersHuman Molecular Genetics, 1993
- Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: Their incidence and clinical features of defined genotypesHuman Mutation, 1993
- Molecular characterization of cystic fibrosis: 16 Novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctionsGenomics, 1992